Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

miR-29a-5p prevents the formation of early hair structures by targeting a gene important for hair growth and is regulated by a complex network involving lncRNA627.1.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Fzd2 is important for skin and hair development through various signaling ways.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

AP-2α and AP-2β are crucial for healthy skin and hair.

Ritlecitinib works well and is safe for treating alopecia areata.

Dupilumab effectively treated severe alopecia areata in a child.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Killing specific cells in hair follicles can lead to hair growth problems in mice.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

MC-1R in skin cells may influence inflammation and collagen production.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Ritlecitinib helps adolescents with severe alopecia areata regrow scalp hair and normalize body hair and nails.